Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / Johnson & Johnson buying Swiss biotech firm Actelion for $30bn
  • Business

    Johnson & Johnson buying Swiss biotech firm Actelion for $30bn

    Abheet Sethi
    Written by
    Abheet Sethi
    Mail
    Last updated on Jan 28, 2017, 05:30 am
    Johnson & Johnson buying Swiss biotech firm Actelion for $30bn
    Credits:
  • American healthcare major Johnson & Johnson (J&J) is acquiring Swiss biotech firm Actelion in a $30 billion all-cash deal.

    This is the largest European drug takeover in 13 years. J&J will now have access to Actelion's high-price, high-margin medicine range used to cure rare diseases.

    However, the deal doesn't include Actelion's R&D unit which will be spun off into a different entity.

  • In this article
    What is Actelion J&J paid 23% more than Actelion's share price How J&J benefits from the deal
  • Information

    What is Actelion

  • Actelion was co-founded by cardiologist Jean-Paul Clozel, his pediatrician wife Martine and their friends in 1997. Actelion specializes in orphan (rare) diseases and has 29 operative affiliates around the world, including the US, Brazil, Canada and Japan.

  • Big deal!

    J&J paid 23% more than Actelion's share price

    J&J paid 23% more than Actelion's share price
    Credits:
  • The deal allows J&J to purchase all outstanding shares of Actelion for $280. J&J's offer represents a 23% percent premium to Actelion's closing price on Wednesday.

    The offer also represents an 80% premium to Actelion's November 23 closing price, which is when acquisition reports emerged.

    "J&J is paying a lot and R&D is not even included, just a substantial minority stake," a trader said.

  • Tax saving

    How J&J benefits from the deal

    How J&J benefits from the deal
    Credits:
  • The deal will help J&J diversify its drug portfolio even as its biggest product Remicade, the arthritis drug, faces cheaper competition.

    J&J tapped into its $42bn offshore cash trove to pay for Actelion's acquisition.

    This will allow the American drug major to lower its US tax bills as the American government plans to overhaul the tax code by bringing back offshore untaxed funds.

  • Johnson & Johnson
  • US
  •  
Latest News
  • NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    NewsBytes Briefing: Investigation uncovers Facebook's pro ISIS move, and more
    Science
  • PUBG: New State announced for iOS, Android; Unavailable in India
    PUBG: New State announced for iOS, Android; Unavailable in India
    Science
  • Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Indian versions of 'Suits', 'House', 'Monk', 'SNL' are being planned
    Entertainment
  • Google integrates lightweight HTML5 games into Chrome browser on Android
    Google integrates lightweight HTML5 games into Chrome browser on Android
    Science
  • Sony announces next-generation PSVR headset for the PlayStation 5
    Sony announces next-generation PSVR headset for the PlayStation 5
    Science
Related Timelines
  • Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy
    Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy
    Science
Trending Topics
Bharti Airtel Mukesh Ambani WhatsApp Reliance Jio OPPO Isha Ambani
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Narendra Modi Facebook YouTube Hollywood News WhatsApp Bollywood News ISRO Rahul Gandhi Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Royal Challengers Bangalore
Toyota Fashion Tips Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics
Avengers Neha Kakkar Premier League Big Bang Theory
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021